11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study (Q37699953)
Jump to navigation
Jump to search
scientific article published on 26 February 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | 11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study |
scientific article published on 26 February 2010 |
Statements
1 reference
11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study (English)
1 reference
Kaj Blennow
1 reference
Juha O Rinne
1 reference
Aren A Okello
1 reference
Jerome Barakos
1 reference
Enchi Liu
1 reference
Michael Grundman
1 reference
Roger Bullock
1 reference
Chester A Mathis
1 reference
Sofia Rodriguez Martinez de Liano
1 reference
Martin Koller
1 reference
Keith M Gregg
1 reference
Dale Schenk
1 reference
Ronald Black
1 reference
26 February 2010
1 reference
1 reference
Identifiers
1 reference